Price-hiking pharma exec Martin Shkreli gets House subpoena
WASHINGTON - House lawmakers have issued a subpoena to compel former Turing Pharmaceuticals CEO Martin Shkreli, reviled for price-gouging, to appear at a congressional hearing next Tuesday.
An aide to the House Committee on Oversight and Government Reform confirmed the news Wednesday. The committee is investigating several companies for exorbitant drug price increases.
Shkreli became notorious for hiking the price of Daraprim, the only approved drug for a rare and sometimes deadly parasitic infection, by 5,000 percent. Since then, Shkreli has been deluged with criticism from patients, politicians and the media, some calling him the "most hated man in America."
Last month, the 32-year-old former hedge fund manager was arrested in New York and charged with securities fraud and conspiracy. The charges stem from another pharmaceutical company he previously ran called Retrophin.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Identical twins at local high school earn $24 million in scholarship offers
Deputy released from hospital months after falling seriously ill with COVID
Former White Castle mayor pleads no contest to felony charge from his...
Coroner: Baby died from gunshot wound after police chase in Mississippi
Wednesday's Health Report
LSU pitcher Matt Beck gets his moment at the plate
Brusly baseball needs extra innings to win regional series with Jennings.
Southern Athletic Director Roman Banks talks about coaching search
Drew Brees and Sean Payton enjoy the Zurich Classic
Legendary Parkview coach Kenny Guillot passes away at 76